Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chromogranin A as Surveillance Biomarker in Patients With cARcinoids (The CASPAR Study)

NCT03817866 is registered in ClinicalTrials.gov with Brahms AG as lead sponsor.

NCT NCT03817866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03817866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chromogranin A as Surveillance Biomarker in Patients With cARcinoids (The CASPAR Study)
Lead sponsor
Brahms AG
Phase
Observational
Overall status
Completed
Start date
January 29, 2019
Completion date
December 14, 2021
Enrollment
175 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal neoplasms, gastric neoplasms, pancreatic neoplasms, small intestinal neoplasms